Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

The development of post-transplantation antibodies against non-HLA autoantigens is
associated with rejection and decreased long-term graft survival. Although our knowledge of …

Anti-angiotensin II type 1 receptor (AT1R) antibodies have been associated with allograft
rejection. We hypothesized that circulating AT1R antibodies might identify kidney transplant …

HLA antigens are polymorphic proteins expressed on donor kidney allograft endothelium
and are critical targets for recipient immune recognition. HLA antibodies are risk factors for …

Background Correlation between antibody-mediated rejection (ABMR) and circulating HLA
donor-specific antibodies (HLA-DSA) is strong but imperfect in kidney transplant (KT) …

Detrimental actions of donor-specific antibodies (DSAs) directed against both major
histocompatibility antigens (human leukocyte antigen [HLA]) and specific non-HLA antigens …

Background Although anti-HLA antibodies (Abs) cause most antibody-mediated rejections of
renal allografts, non-anti–HLA Abs have also been postulated to contribute. A better …

Donor-specific alloantibodies (DSA) can cause acute antibody-mediated rejection (AMR) in
all solid organ allografts. However, long-term outcome in patients with posttransplant DSA …

The major medical advances in our knowledge of the human leukocyte antigen (HLA)
system have allowed us to uncover several gaps in our understanding of alloimmunity …

The current literature suggests that, although complement-fixing antibodies may have some
prognostic value for graft outcome, complement-independent mechanisms of graft injury are …